These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 12804767

  • 1. Pharmacological analysis of a dopamine D(2Short):G(alphao) fusion protein expressed in Sf9 cells.
    Gazi L, Wurch T, Lopéz-Giménez JF, Pauwels PJ, Strange PG.
    FEBS Lett; 2003 Jun 19; 545(2-3):155-60. PubMed ID: 12804767
    [Abstract] [Full Text] [Related]

  • 2. Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity.
    Nickolls SA, Strange PG.
    Biochem Pharmacol; 2003 Apr 01; 65(7):1139-50. PubMed ID: 12663049
    [Abstract] [Full Text] [Related]

  • 3. The influence of G protein subtype on agonist action at D2 dopamine receptors.
    Nickolls SA, Strange PG.
    Neuropharmacology; 2004 Nov 01; 47(6):860-72. PubMed ID: 15527820
    [Abstract] [Full Text] [Related]

  • 4. Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype.
    Cordeaux Y, Nickolls SA, Flood LA, Graber SG, Strange PG.
    J Biol Chem; 2001 Aug 03; 276(31):28667-75. PubMed ID: 11369753
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
    Roberts DJ, Lin H, Strange PG.
    Biochem Pharmacol; 2004 May 01; 67(9):1657-65. PubMed ID: 15081865
    [Abstract] [Full Text] [Related]

  • 6. Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner.
    Pauwels PJ, Tardif S, Colpaert FC.
    Biochem Pharmacol; 2001 Sep 15; 62(6):723-32. PubMed ID: 11551517
    [Abstract] [Full Text] [Related]

  • 7. In vivo reconstitution of dopamine D2S receptor-mediated G protein activation in baculovirus-infected insect cells: preferred coupling to Gi1 versus Gi2.
    Grünewald S, Reiländer H, Michel H.
    Biochemistry; 1996 Dec 03; 35(48):15162-73. PubMed ID: 8952463
    [Abstract] [Full Text] [Related]

  • 8. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 03; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 9. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    Geurts M, Hermans E, Maloteaux JM.
    Eur J Pharmacol; 1999 Oct 08; 382(2):119-27. PubMed ID: 10528146
    [Abstract] [Full Text] [Related]

  • 10. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
    Terasmaa A, Finnman UB, Owman C, Ferré S, Fuxe K, Rinken A.
    Neurosci Lett; 2000 Feb 18; 280(2):135-8. PubMed ID: 10686396
    [Abstract] [Full Text] [Related]

  • 11. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 12. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
    Wurch T, Boutet-Robinet EA, Palmier C, Colpaert FC, Pauwels PJ.
    J Pharmacol Exp Ther; 2003 Jan 27; 304(1):380-90. PubMed ID: 12490615
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation.
    Quirk K, Roberts DJ, Strange PG.
    Br J Pharmacol; 2007 May 30; 151(1):144-52. PubMed ID: 17351658
    [Abstract] [Full Text] [Related]

  • 15. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg, Mikaels, Mohell N.
    J Pharmacol Exp Ther; 1998 Apr 30; 285(1):119-26. PubMed ID: 9536001
    [Abstract] [Full Text] [Related]

  • 16. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar 30; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 17. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.
    Gazi L, Nickolls SA, Strange PG.
    Br J Pharmacol; 2003 Mar 30; 138(5):775-86. PubMed ID: 12642378
    [Abstract] [Full Text] [Related]

  • 18. Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins.
    Wurch T, Matsumoto A, Pauwels PJ.
    FEBS Lett; 2001 Oct 19; 507(1):109-13. PubMed ID: 11682068
    [Abstract] [Full Text] [Related]

  • 19. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor.
    Pregenzer JF, Alberts GL, Im WB.
    Neurosci Lett; 1997 Apr 25; 226(2):91-4. PubMed ID: 9159497
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
    Wilson J, Lin H, Fu D, Javitch JA, Strange PG.
    J Neurochem; 2001 Apr 25; 77(2):493-504. PubMed ID: 11299312
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.